EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 22 / No 12 (Décembre 2006) Med Sci (Paris), 22 12 (2006) 1095-1100 References
Free Access
Issue
Med Sci (Paris)
Volume 22, Number 12, Décembre 2006
Page(s) 1095 - 1100
Section M/S revues
DOI https://doi.org/10.1051/medsci/200622121095
Published online 15 December 2006
  1. Brown AJ, Dusso AS, Slatopolsky E. Vitamin D. Am J Physiol 1999; 277 : F157–75. [Google Scholar]
  2. Cheng JB, Levine MA, Bell NH, et al. Genetic evidence that the human CYP2R1 is a key vitamin D 25-hydroxylase. Proc Natl Acad Sci USA 2004; 101 : 7711–5. [Google Scholar]
  3. Souidi M, Dubrac S, Parquet M, Lutton C. Hepatic and extrahepatic sterol 27-hydroxylase: roles in cholesterol and bile acid metabolism and associated diseases. Gastroenterol Clin Biol 2003; 27 : 100–11. [Google Scholar]
  4. Prosser DE, Jones G. Enzymes involved in the activation and inactivation of vitamin D. Trends Biochem Sci 2004; 29 : 664–73. [Google Scholar]
  5. Nykjaer A, Dragun D, Walther D, et al. endocytic pathway essential for renal uptake and activation of the steroid 25-(OH) vitamin D3 Cell 1999; 96 : 507–15. [Google Scholar]
  6. Leheste JR, Melsen F, Wellner M, et al. Hypocalcemia and osteopathy in mice with kidney-specific megalin gene defect. FASEB J 2003; 17 : 247–9. [Google Scholar]
  7. Garabédian M. La 1,25dihyroxyvitamine D et son récepteur. Rev Rhum 2000; 67 (suppl 2) : 39–41. [Google Scholar]
  8. Miller WL, Portale AA. Vitamin D 1 alpha hydroxylase. Trends Endocrinol Metab 2000; 11 : 315–9. [Google Scholar]
  9. Garcion E, Wion-Barbot N, Montero-Menei CN, et al. New clues about vitamin D functions in the nervous system. Trends Endocrinol Metab 2002; 13 : 100–5. [Google Scholar]
  10. Schuessler M, Astecker N, Herzig G, et al. Skin is an autonomous organ in synthesis, two-step activation and degradation of vitamin D3: CYP27 in epidermis completes the set of essential vitamin D3-hydroxylases. Steroids 2001; 66 : 399–408. [Google Scholar]
  11. Post SM, Duez H, Gervois PP, et al. Fibrates suppress bile acid synthesis via peroxisome proliferator-activated receptor-alpha-mediated downregulation of cholesterol 7alpha-hydroxylase and sterol 27-hydroxylase expression. Arterioscler Thromb Vasc Biol 2001; 21 : 1840–5. [Google Scholar]
  12. Chen W, Chiang JY. Regulation of human sterol 27-hydroxylase gene (CYP27A1) by bile acids and hepatocyte nuclear factor 4alpha (HNF4alpha). Gene 2003; 313 : 71–82. [Google Scholar]
  13. Quinn CM, Jessup W, Wong J, et al. Expression and regulation of sterol 27-hydroxylase (CYP27A1) in human macrophages: a role for RXR and PPARgamma ligands. Biochem J 2005; 385 : 823–30. [Google Scholar]
  14. Eloranta JJ, Kullak-Ublick GA. Coordinate transcriptional regulation of bile acid homeostasis and drug metabolism. Arch Biochem Biophys 2005; 433 : 397–412. [Google Scholar]
  15. Armbrecht HJ, Hodam TL, Boltz MA. Hormonal regulation of 25-hydroxyvitamin D3-1alpha-hydroxylase and 24-hydroxylase gene transcription in opossum kidney cells. Arch Biochem Biophys 2003; 409 : 298–304. [Google Scholar]
  16. Hewison M, Zehnder D, Bland R, Stewart PM. 1α-Hydroxylase and the action of vitamin D. Mol Endocrinol 2000; 25 : 141–8. [Google Scholar]
  17. Schiavi SC, Kumar R. The phosphatonin pathway: new insights in phosphate homeostasis. Kidney Int 2004; 65 : 1–14. [Google Scholar]
  18. Gao XH, Dwivedi PP, Omdahl JL, et al. Calcitonin stimulates expression of the rat 25-hydroxyvitamin D3-24-hydroxylase (CYP24) promoter in HEK-293 cells expressing calcitonin receptor: identification of signaling pathways. J Mol Endocrinol 2004; 32 : 87–98. [Google Scholar]
  19. Chen KS, DeLuca HF. Cloning of the human 1 alpha, 25-dihydroxyvitamin D-3 24-hydroxylase gene promoter and identification of two vitamin D-responsive elements. Biochem Biophys Acta 1995; 1263 :1–9. [Google Scholar]
  20. Murayama A, Kim M, Yanagisawa J, et al. Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching. EMBO J 2004; 23 : 1598–608. [Google Scholar]
  21. Pascussi JM, Robert A, Nguyen M, et al. Possible involvement of pregnane X receptor-enhanced CYP24 expression in drug-induced osteomalacia. J Clin Invest 2005; 115 : 177–86. [Google Scholar]
  22. Dusso AS, Brown AJ, Slatopolsky E. Vitamin D. Am J Physiol Renal Physiol 2005; 289 : F8–28. [Google Scholar]
  23. Norman AW, Ishizuka S, Okamura WH. Ligands for the vitamin D endocrine system: different shapes function as agonists and antagonists for genomic and rapid response receptors or as a ligand for the plasma vitamin D binding protein. J Steroid Biochem Mol Biol 2001; 76 : 49–59. [Google Scholar]
  24. Van Etten E, Mathieu C. Immunoregulation by 1,25-dihydroxyvitamin D3 : Basic concepts. J Steroid Biochem Mol Biol 2005; 97 : 93–101. [Google Scholar]
  25. Holick MF. Vitamin D : A millenium perspective. J Cell Biochem 2003; 88 : 296–307. [Google Scholar]
  26. Holick MF. Noncalcemic actions of 1,25-dihydroxyvitamin D3 and clinical applications. Bone 1995; 17 (suppl 2) : S107–11. [Google Scholar]
  27. Adorini L. Immunomodulatory effects of vitamin D receptor ligands in autoimmune diseases. Int Immunopharmacol 2002; 2 : 1017–28. [Google Scholar]
  28. St-Arnaud R, Glorieux FH. 24, 25-Dihydroxyvitamin D: active metabolite or inactive catabolite ? Endocrinology 1998; 139 : 3371–4. [Google Scholar]
  29. Garabédian M, Menn S, Walrant-Debray O, et al. Prevention of child and adolescent vitamin D deficiency. II. Validation of a decision-making abacus based on sun exposure and vitamin D intakes. Arch Pediatr 2005; 12 : 410–9. [Google Scholar]
  30. Maugars Y, Glémarec J, Guillot P, et al. Métabolisme phosphocalcique et ostéomalacie. Rev Rhum 2000; 67 (suppl 2) : 95–8. [Google Scholar]
  31. Breuil V, Euller-Ziegler. Nutrition et vieillissement osseux : l’ostéoporose. Nutr Clin Metab 2004; 18 : 212–8. [Google Scholar]
  32. Gascon-Barré M. Antiepileptic drugs and bone health. In : Dawson-Hughes B, Holick MF, eds. Nutrition and bone health. Totowa-New Jersey, USA : Humana Press, 2004 : 647–66. [Google Scholar]
  33. Pascussi JM, Vilarem MJ. Ostéomalacie consécutive à la prise prolongée de médicaments. Sur la piste de PXR, un récepteur impliqué dans la détoxication. Med Sci (Paris) 2005; 21 : 582–3. [Google Scholar]
  34. Kato S, Yoshizazawa T, Kitanaka S, et al. Molecular genetics of vitamin D- dependent hereditary rickets. Horm Res 2002; 57 : 73–8. [Google Scholar]
  35. Dumas R. Les rachitismes vitaminorésistants. Arch Pediatr 1999; 6 : 715–9. [Google Scholar]
  36. Souberbielle JC, Friedlander G, Kahan A, Cormier C. Evaluating vitamin D status. Implications for preventing and managing osteoporosis and other chronic diseases. Joint Bone Spine 2006; 73 : 249–53. [Google Scholar]
  37. Holick MF. Defects in the synthesis and metabolism of vitamin D. Exp Clin Endocrinol Diabetes 1995; 103 : 219–27. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.